Ensysce Biosciences (ENSC) Cash from Operations (2018 - 2025)
Ensysce Biosciences (ENSC) posted Cash from Operations of -$1.87 million for Q3 2025, compared with -$1.02 million a year earlier.
Ensysce Biosciences (ENSC) Cash from Operations (2018 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Cash from Operations at Ensysce Biosciences was -$7.04 million; for FY2024, it came in at -$7.5 million.
- In prior years, Ensysce Biosciences' Cash from Operations was -$10.78 million in FY2023, -$17.89 million in FY2022, -$8.24 million in FY2021 and -$1.25 million in FY2020.
- Quarterly Cash from Operations has run from a low of -$6.71 million in Q3 2022 to a high of -$132,312 in Q2 2021 over five years.
- According to Business Quant data, Cash from Operations for the three prior quarters was -$2.71 million (Q2 2025), -$1.71 million (Q1 2025) and -$764,090 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Ensysce Biosciences | 1.07 Mn | -10.50 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1.87 Mn |
| Jun 30, 2025 | -2.71 Mn |
| Mar 31, 2025 | -1.71 Mn |
| Dec 31, 2024 | -764,090.00 |
| Sep 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -2.31 Mn |
| Mar 31, 2024 | -3.41 Mn |
| Dec 31, 2023 | -1.80 Mn |
| Sep 30, 2023 | -2.26 Mn |
| Jun 30, 2023 | -3.11 Mn |
| Mar 31, 2023 | -3.61 Mn |
| Dec 31, 2022 | -3.30 Mn |
| Sep 30, 2022 | -6.71 Mn |
| Jun 30, 2022 | -4.44 Mn |
| Mar 31, 2022 | -3.44 Mn |
| Dec 31, 2021 | -3.77 Mn |
| Sep 30, 2021 | -3.82 Mn |
| Jun 30, 2021 | -132,312.00 |
| Mar 31, 2021 | -517,149.00 |
| Dec 31, 2020 | -533,857.00 |
Ensysce Biosciences Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ENSC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();